Answers are grounded in this paper and cite their sources.
ET-1 functions as a full contractile agonist that induces Ca2+-antagonist insensitive Ca2+ influx, membrane depolarization, and intracellular Ca2+ release, rather than acting solely as an endogenous voltage-sensitive Ca2+ channel activator.
Summary The effects of endothelin-1 (ET-1) on tension and membrane potential in rat isolated mesenteric resistance vessels (MRVs) and on 45Ca influx, 45Ca efflux, inositol-1,4,5-trisphosphate (IP3) production, and cytoplasmic Ca24 concentration ([Ca2+]i) in cultured aortic smooth muscle cells were compared with those of other agonists. ET-1 induced contractions of the MRVs, which were slow in onset, but reached a similar maximum amplitude (at 10 nM ET-1) as that seen with norepinephrine (NE, 10$mUM) or [arg8]vasopressin (AVP, 0.1 $mUM). The EC50 for ET-1 was 1.3 $$ 0.1 nM. Removal of extracellular Ca2+ reduced ET-1-induced contractions to 11 $$ 3% of those in Ca2+- containing medium. With NE, the same procedure reduced contractions to 47 $$ 7% of those in Ca2+-containing medium, while with AVP, the reduction was similar in magnitude to that induced by ET-1 (11 $$5% of those in Ca2+-containing medium). Relaxation of ET-1-induced and NE-induced contractions by diltiazem was not complete (maximal at 58 $$ 6% with 10 $mUM diltiazem after 6 nM ET-1, and at 70 $$ 3% after 0.1 $mUM NE), in contrast to that of 80 mM K.+-induced contractions, which were potently (IC50 = 0.2 $mUM) and completely reversed (100% relaxation at 10 $mUM diltiazem). ET-1 (6 nM) caused a small but significant depolarization of the MRVs (∼7 mV), the magnitude of which was only about one-third of that induced by equieffective contractile concentrations of NE and AVP. The voltage-sensitive Ca2+ channel agonist Bay K. 8644 (1 $mUM), in contrast to ET-1, NE, and AVP, produced a small contraction (30 $$ 2% of the maximum response to NE), but no further depolarization when added in the presence of 15 mM K+ (which elicited ∼ 12 mV depolarization but no contraction). In cultured aortic smooth muscle cells (SMCs), ET-1 (10 nM) induced a Ca2+-antagonist-insensitive stimulation of 45Ca influx, the magnitude of which was less than one-half of that induced by AVP (0.1 $mUM) or angiotensin II (A II; 0.1 $mUM), these responses also being Ca2+-antagonist-insensitive. The EC50 for this ET-1-induced stimulation was 0.8 $$ 0.1 nM45Ca influx stimulated in these cells by Bay K 8644, in contrast, is Ca2+ antagonist-sensitive. ET-1 stimulated 45Ca efflux as well, indicating that it released Ca2+ from intracellular stores. The production of IP3 was also increased by ET-1 (10 nM), but again only to less than one-half the extent to which it was increased by maximally active concentrations of A II, AVP, or ATP. ET-1 (10 nM) caused a rise of [Ca2+]i, measured by the fluorescent indicator Fura-2, from a basal level of 106 $$ 6 to 294 $$ 36 nM transiently (within ∼20 s), then to a sustained level of 172 $$ 10 nM. Neither diltiazem (10 $mUM) nor darodipine (100 nM) significantly altered these responses. These results do not support the original speculation that ET-1 is simply an endogenous voltage-sensitive Ca:+ channel activator. On the contrary, ET-1 appears rather similar to other agonists in that it causes Ca2+-antagonist insensitive 45Ca influx, depolarizes cell membranes, and releases intracellular Ca2+ probably via IP3 production. A remaining enigma is, however, that while ET-1 appears to be a partial agonist for those processes that relate to the Ca2+ influx (45Ca uptake and membrane depolarization) that supports sustained contractions, it is a full contractile agonist in the MRVs and a full agonist in producing a sustained rise in [Ca2+]i in the cultured aortic cells. This paradox may suggest an additional effect by ET-1, perhaps one related to intracellular Ca2+ sequestration or extrusion.
No takes yet. Share an insight, caveat, or question.
Wallnöfer et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: